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The promoter of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10) has two AP-1 cis-
response elements, respectively located at positions 062 and 094 relative to the transcription start site (Wymer et al.,
1989, J. Virol. 63, 2773–2784). Chloramphenicol acetyl transferase (CAT) analysis with hybrid constructions of the CAT
structural gene and the ICP10 promoter or its mutants and gel retardation studies were used to examine the role of the
AP-1 cis-response elements in expression from the ICP10 promoter. Basal expression from the wild-type promoter was
significantly (75–90%) reduced by mutation of the upstream or downstream AP-1 element. Mutation in the upstream AP-1
element also caused a 60% reduction in c-Jun-mediated activation. Activation was decreased 40% by mutation in the
downstream AP-1 element and it was abrogated by mutation of both elements. Similar results were obtained for ACT-
deleted mutants and mutants in which CT was mutated to AG. The trans-activation by Vmw110 was also reduced by mutation
of the AP-1 elements (10- and 2-fold for the upstream and downstream element, respectively) and it was abrogated by
mutation of both AP-1 elements. Mutation of nucleotides adjacent to the AP-1 cis-response elements had no effect on
trans-activation. Gel retardation assays with a DNA probe representing the wild-type ICP10 promoter and nuclear extracts
from HSV-1-infected cells identified one complex that was not seen with mock-infected cells or with cells infected with a
Vmw110-deleted mutant. The complex was not seen when HSV-1-infected cells were reacted with an AP-1-mutant DNA
probe, and its formation was competed by an AP-1 but not a mutant AP-1 oligonucleotide. The migration of this complex
was retarded by c-Fos antibody, suggesting that both AP-1 and Vmw110 are involved in its formation. A mutant deleted in
all sequences upstream of the TATA box was also activated by Vmw110, but this activation was only 2-fold lower than that
seen for the wild type and significantly higher (10-fold) than that seen for the double AP-1 mutants. The data suggest that
AP-1 elements play a crucial role in ICP10 gene expression/activation. q 1997 Academic Press
INTRODUCTION or g, forms a continuum of genes differing in their timing
and dependence on viral DNA synthesis for expression
Herpes simplex virus (HSV) genes are classified into
(reviewed in Roizman and Sears, 1996).
three major kinetic classes on the basis of the time and
Ribonucleotide reductase (RR) reduces ribonucleo-
regulation of their synthesis during productive infection. tides to deoxyribonucleotides, thereby providing precur-
The five immediate-early (IE), or a, genes are transcribed sors for DNA synthesis. HSV-1 and HSV-2 encode their
as early as 2 hr postinfection (p.i.) in the presence of the own RR enzymes which, like the mammalian and bacte-
protein inhibitor cycloheximide, i.e., in the absence of de rial enzymes, consist of two subunits (Cohen, 1985; Dutia,
novo protein synthesis. Expression of IE genes is initi- 1983; Bacchetti et al., 1986; Frame et al., 1985; Ingemar-
ated by the interaction of the virion tegument protein son and Lankinen, 1987; Swain and Galloway, 1986). The
Vmw65 (also designated VP16 or a-TIF) with the oct-1 large subunit (RR1), designated ICP6 for HSV-1 and
cellular transcription factor at the octamer/TAATGAARAT ICP10 for HSV-2, has a molecular mass of 140 kDa and
sequence in the regulatory region of the IE gene promot- is encoded by a 5.0-kb mRNA derived from the unique
ers (O’Hare and Hayward, 1985). Accordingly, IE genes long region of the viral DNA (UL39) at map units 0.562–
are more precisely defined by the presence of the oc- 0.597 (McLauchlan and Clements, 1983; Swain and Gal-
tamer/TAATGAARAT sequence within several hundred loway, 1986). The small subunit (RR2) has a molecular
base pairs upstream of the cap site. The synthesis of the mass of 38 kDa and it is encoded by a 1.2-kb transcript,
next class of HSV genes, designated early (E) or b, be- the 3*-end of which is shared with the RR1 transcript
gins at 5–7 hr p.i. and it requires competent IE gene (Anderson et al., 1981; McLauchlan and Clements, 1983).
expression, specifically a functional ICP4 protein. The Because RR activity is required for DNA synthesis, RR
appearance of the E genes signals the onset of viral DNA plays a major role in virus growth. Thus, HSV-1 mutants
synthesis. The third class of HSV genes, designated L deleted in RR1 replicate normally in cell culture under
exponentially growing conditions, but they are replication
defective in cells that cannot provide the compensating1 To whom reprint requests should be addressed.
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RR activity (Goldstein and Weller, 1988). In addition to its
role in RR activity, the RR1 proteins have an intrinsic
protein kinase (PK) activity which is encoded by the
amino-terminal domain of the molecule (Chung et al.,
1989, 1990; Luo et al., 1991; Paradis et al., 1991; Ali et
al., 1991; Luo and Aurelian, 1992; Conner et al., 1992a;
Cooper et al., 1995; Peng et al., 1996; Nelson et al., 1996).
The PK domain is not conserved in the large subunit of
other herpesviruses, nor in mammalian or bacterial RR1
proteins (Chung et al., 1989). In constitutively expressing
cells, the ICP10 PK activity is required in order to activate
the ras signaling pathway, causing increased cell prolif-
eration and anchorage-independent growth (Smith et al.,
1992, 1994; Hunter et al., 1995). However, the role of the
RR1 PK activity in virus replication is still unclear.
The kinetics of induction of the HSV-1 and HSV-2 RR
enzymatic activity are characteristic of other E genes
involved in viral DNA synthesis (Honess and Roizman,
1974; Langelier and Buttin, 1981; Bacchetti et al., 1986).
This likely reflects the kinetics of the RR2 protein synthe-
sis (Wagner, 1983), since the synthesis of RR1, like that
of IE genes, is first seen as early as 2 hr p.i. and in the
presence of cycloheximide (Strnad and Aurelian, 1976;
Anderson et al., 1981; Watson et al., 1979; Wymer et al.,
1989, 1992). The RR1 promoter has an octamer/TAATGA- FIG. 1. Schematic representation of chimeric CAT constructs con-
RAT sequence that responds to the Vmw65/oct-1 com- taining the wild-type (pJW24) and mutant ICP10 promoters. (A) The
cloning of the 649-bp HindIII/BamHI fragment (ICP10 promoter) intoplex and is presumably responsible for the expression
the pCATB* vector was described (Wymer et al., 1989). It contains oneof the RR1 transcript with IE kinetics (Wymer et al., 1989,
OTF-1/TAATGARAT and five SP-1 motifs as well as two AP-1 elements1992; Desai et al., 1993). RR1 is the only E gene which
located at positions 094 (upstream) and 062 (downstream) relative to
is activated by Vmw110, but not by ICP4 (Wymer et al., the transcription initiation site. The wild-type and mutant sequences at
1989, 1992; Desai et al., 1993). Also, the RR1 promoter position095 to055 are listed. The wild-type promoter (pJW24) contains
two consensus AP-1-binding sites. pJZ2 and pJZ3 are mutated in theis the only HSV promoter that has AP-1 cis-response
upstream AP-1 element. The first is ACT deleted; the second has aelements, and it specifically binds in vitro-translated c-
CT:AG mutation. pJZ4 is mutated in the downstream AP-1 elementJun protein (Wymer et al., 1989, 1992). AP-1 describes a
(CT:AG). pJZ24 and pJZ34 are double AP-1 mutants of pJZ2 and pJZ3,
broad class of transcription factors that consist of homo- respectively. pJZ54 and pJZ53 are examples of the non-AP-1 mutants
and heterodimers of two Jun or one Jun and one Fos studied in these series. (B) pJZD5 is deleted in all elements upstream
of the TATA box by PvuI partial digestion.family proteins that complex to the same DNA consensus
sequence (TGACTCA) and are important in the regulation
of gene expression (Lee et al., 1987; Lamph et al., 1988).
trated as described (Strnad and Aurelian, 1976; StoweHowever, the role of the AP-1 cis-response elements in
and Stowe, 1986).RR1 regulation is still unclear. The studies described in
this report were designed to address this question.
Plasmids
Chimeric chloramphenicol acetyltransferase (CAT)MATERIALS AND METHODS
constructions were prepared in pCATB* (O’Hare and Hay-
Cells and virus
ward, 1984), containing the CAT structural gene without
eukaryotic promoter sequences. The target constructionVero (African green monkey) cells were grown in Ea-
gle’s minimum essential medium (EMEM) containing 10% pICP10-cat (pJW24) contains the 649-bp wild-type pro-
moter of ICP10 (position 0544 to /105 relative to thefetal calf serum (FCS), 100 units/ml penicillin G, and 100
mg/ml streptomycin sulfate. F9 (mouse embryonal carci- mRNA cap site) inserted 5* to the CAT gene (Wymer et
al., 1989). The 649-bp BamHI/HindIII fragment fromnoma) cells were grown in Dulbecco’s modified Eagle
medium with 15% FCS and antibiotics. SK-N-SH (human pJW24 was subcloned into M13mp18 and subjected to
oligonucleotide-directed mutagenesis using the Muta-neuroblastoma) cells were grown in EMEM with 10%
FCS, 1 mM Na pyruvate, 11 nonessential amino acids, Gene system (Bio-Rad, Inc.) according to the manufactur-
er’s instructions. As summarized in Fig. 1, oligonucleo-and antibiotics. The wild-type HSV-1 (strain F) and the
Vmw110-defective virus dl1403 were prepared and ti- tides 5*-ACACCCCCCTGAAGCAGGAGATAGGC-3* and
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5*-CCTTAGATTGAAGCAGCACACG-3* were respectively infected (with PBS) or infected with HSV-1 (F) or dl1403
(5 PFU/cell), respectively, and incubated in medium con-used to generate mutants pJZ3 and pJZ4 which have a
2-base mutation (CT to AG) in the upstream (pJZ3) or taining 10% serum. Nuclear extracts were prepared from
5-hr infected cells according to Dignam et al. (1983). Thedownstream (pJZ4) AP-1 elements. Mutant pJZ2 has a 3-
base deletion (ACT) in the upstream AP-1 element wild-type (pICP10-cat, pJW24) and double AP-1 mutant
(pJZ34) promoters were restriction digested with AflIIIwhich was generated with the oligonucleotide 5*-ACAC-
CCCCCTGCAGGAGATAGGC-3*. These mutations elimi- and PvuI to generate 61-bp fragments containing the two
AP-1 elements. The DNA fragments were end-labelednate the HinfI sites in the AP-1 motifs, thereby allowing
mutant screening. To generate mutants pJZ24 and pJZ34 with [a-32P]dCTP by Klenow fill-in reaction, separated by
8% polyacrylamide gel electrophoresis in 90 mM Tris-in both AP-1 motifs, sequential oligonucleotide-directed
mutagenesis was performed using oligonucleotides borate, 2.5 mM EDTA (TBE), and isolated from the gels
by overnight elution in 0.5 M ammonium acetate, 10 mM5*-ACACCCCCCTGCAGGAGATAGGC-3* and 5*-CCTTA-
GATTGAAGCAGCACACG-3* (mutant pJZ24) or 5*-ACAC- magnesium acetate, 1 mM EDTA, 0.1% SDS, as de-
scribed (Feng et al., 1993). The synthetic double-strandedCCCCCTGAAGCAGGAGATAGGC-3* and 5*-CCTTAGAT-
TGAAGCAGCACACG-3* (mutant pJZ34). Single and dou- oligonucleotides AP-1 (5*-GATCCAAGCTATGACTCATC-
CGGTCTAGAA-3*) and DAP-1 (5*-GATCCAAGCTATGAA-ble AP-1 mutants were screened by HinfI digestion and
mutations were confirmed by sequence analysis. Control CCATCCGGTCTAGAA-3*) were used as specific and
nonspecific competitors, respectively. Typical gel retar-mutations, outside of the AP-1 elements, were performed
with oligonucleotides 5*-CCCTGACTCAGAAGATAGG- dation mixtures contained 20 mM HEPES (pH 7.9), 50
mM KCl, 5 mM MgCl2 , 0.5 mM DTT, 0.2 mg/ml BSA, 5%CATATCCGTCTTAGATTGACT-3* (JZ54) and 5*-CCCTG-
ACTCAAGAGATAGGCATATCCGTCTTAGATTGACT-3* glycerol, and 2 mg poly(dI-dC)–poly(dI-dC) (Pharmacia)
used as nonspecific competitor. They were incubated(JZ53) and were confirmed by sequence analysis. Mutant
pJZD5, which is deleted in the upstream region of the with 2 mg nuclear protein and 4 fmol radiolabeled DNA
fragment for 40 min on ice. The assays were electropho-ICP10 promoter from nucleotide 0544 to 056, was cre-
ated by PvuI partial digestion of the wild-type plasmid resed at 10 V/cm and 47 through a 4% native polyacryl-
amide gel (29:1, bisacrylamide) in 0.251 TBE, which hadpICP10-cat. The mutated promoters were recloned into
pCATB* to generate the mutant CAT chimeras schemati- been prerun for 2 hr. For supershift assays, anti-c-fos
antibody (Oncogene Science; 1:25 dilution) was includedcally represented in Fig. 1. The c-Jun (pSV-junA)-,
Vmw110 (pIGA15)-, and Vmw65 (pGH62)-expressing in the incubation mixture. The c-fos antibody does not
bind DNA. Its concentration was determined by previousplasmids were described (O’Hare and Hayward, 1985;
Wymer et al., 1989, 1992). titration with the 61-bp DNA fragment containing the AP-
1 elements.DNA transfection and CAT assays
Cells (105/well) were plated 24 hr prior to transfection RESULTS
into six-well cluster dishes (6 1 35 mm; Costar). DNA
AP-1 cis-response elements are involved in serum-transfection was performed by Lipofectamine (GIBCO
mediated regulation of ICP10 expressionBRL, Gaithersburg, MD) according to the manufacturer’s
instructions. Briefly, 1.0 mg of target DNA and various Previous studies have shown that the ICP10 promoter
concentration (0.1–2.0 mg) of trans-activator DNA were has two consensus AP-1 elements (TGACTCA) located
incubated with 10 ml Lipofectamine for 30 min at room at positions 062 and 094, relative to the transcription
temperature to allow formation of the DNA–liposome start site. These elements are not present in the promoter
complex, and the mixture, together with 1 ml of EMEM, region of other HSV genes. To better characterize the two
was overlaid on the cells. After 5-hr incubation at 377, AP-1-binding sites in the ICP10 promoter, we generated a
the cells were washed once with 11 EMEM and grown series of site-directed or deletion mutants in the putative
in fresh medium containing 10% FCS (high serum) or upstream (094) and/or downstream (062) AP-1 response
0.5% FCS (low serum). Parallel cotransfections employed element of the chimeric wild-type ICP10 promoter–CAT
pBR322 as a nonspecific DNA to equalize nucleic acid construct, pICP10-CAT (Fig. 1). Because serum contains
concentration effects. Cells were harvested at 44–48 hr growth factors which stimulate the induction of AP-1 ac-
posttransfection and stored at 0207 until assayed. CAT
tivity, we examined CAT expression from pICP10-CAT
assay was performed and analyzed as described pre-
and its AP-1 mutants in transient expression assays us-
viously (Wymer et al., 1989). pSV2CAT was used as a ing Vero cells exposed to high (10%) or low (0.5%) serum
positive control and the parent pCATB* as a negative
concentrations.
control.
As shown in Fig. 2, when Vero cells were incubated
Gel retardation assay in the presence of 10% serum, the basal CAT activity
from the AP-1 mutants was significantly (75–90%) lowerAssays were performed as we previously described
(Wymer et al., 1989) with extracts of Vero cells, mock than that seen with the wild-type promoter. In 0.5% se-
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that expression from the ICP10 promoter is TPA inducible
and depends on AP-1 cis-response elements.
AP-1 elements in the ICP10 promoter are involved in
the regulation of basal expression
In order to further evaluate the contribution of AP-1
factors toward basal expression from the ICP10 pro-
moter, we examined CAT expression from pICP10-cat
and the double mutant pJZ24, in various cell lines. We
used Vero cells because they retain some AP-1 activity
when cultured in 0.5% serum for less than 24 hr, SK-N-
SH cells because neuronal cells have low AP-1 levels
(Valyi-Nagy et al., 1991), and F9 cells because they lack
AP-1 (Angel et al., 1989). Cells were transfected with
FIG. 2. Effect of serum concentration on CAT expression from the
pICP10-cat or pJZ24 and exposed to low serum (0.5%).wild-type ICP10 promoter and its AP-1 mutants. Vero cells were trans-
CAT activity was determined 40 hr later. Under thesefected with 1.0 mg DNA and exposed to high (10%) or low (0.5%) serum
concentrations. CAT activity was measured at 40 hr after transfection conditions, basal expression from pICP10-cat was
and results are expressed as CAT activity relative to the wild-type nearly undetectable (0.6% conversion) in F9 cells that
ICP10 construct (pICP10-cat, pJW24) in 10% serum. pJZ2 and pJZ3, lack AP-1, but it was somewhat higher (1.6% conversion)
upstream AP-1 mutant; pJZ4, downstream AP-1 mutant; pJZ24 and
in Vero cells (Fig. 4). This difference reflects the pres-pJZ34, double AP-1 mutants.
ence of endogenous AP-1 in Vero cells, since basal
expression from the double AP-1 mutant pJZ24 was re-
rum, the basal activity for the wild-type promoter was duced to levels similar to those seen in F9 cells (0.5%
90% lower than that seen in 10% serum but there was conversion) (Fig. 4).
no further reduction in activity due to mutation of the AP-
AP-1 elements in the ICP10 promoter are involved in1 elements. The data suggest that basal expression from
c-Jun-mediated activationthe ICP10 promoter is serum dependent, and it is deter-
mined primarily by the two AP-1 cis-response elements. To determine whether AP-1 is involved in activation of
the ICP10 promoter, we examined the ability of c-Jun to
AP-1 elements in the ICP10 promoter are required for induce CAT expression from pICP10-cat and its AP-1
TPA activation mutants. Vero, SK-NSH, and F9 cells were cotransfected
with pICP10-cat and the c-Jun expression plasmid pSV-In order to further examine the role of the AP-1 cis-
junA and CAT activity was determined at 40 hr post-response elements in expression from the ICP10 pro-
transfection. In all three cell lines, cotransfection with c-moter, we examined the effect of 12-O-tetradecanoylph-
orbol-13-acetate (TPA), which is known to mediate gene
activation through AP-1 induction (Lee et al., 1987, Lamph
et al., 1988; Angel and Karin, 1991) on CAT expression
from pICP10-cat and its AP-1 mutants. The studies were
done in human neuroblastoma cells (SK-N-SH) cultured
(24 hr) in medium containing low (0.5%) serum concentra-
tions, because expression of cellular IE genes, such as c-
Fos, is nearly undetectable in cells of the nervous system
under unstimulated conditions (Valyi-Nagy et al., 1991).
SK-NSH cells were transfected with pICP10-cat or the
double AP-1 mutants pJZ24 or pJZ34. At 5 hr after trans-
fection they were exposed to 100 mg/ml TPA and CAT
activity was determined at 40 hr posttransfection. As
shown in Fig. 3, CAT activity from pICP10-cat (pJW24)
was undetectable in cells that were not treated with TPA, FIG. 3. TPA induction of the ICP10 promoter. SK-N-SH cells were
cultured for 24 hr in 0.5% serum, then transfected with 1.0 mg pJW24but it was significantly increased (fivefold) by TPA treat-
(wild type), pJZ24, or pJZ34 (double AP-1 mutants) DNA. At 5 hr afterment. This increase in CAT activity was similar to that
transfection duplicate cultures were exposed, or not, to 100 mg/ml TPAseen for TPA-treated cells transfected with pSV2CAT in medium without serum and CAT activity was determined 40 hr later.
(threefold), a known TPA-inducible plasmid. By contrast, pSV2CAT, the TPA-inducible plasmid, served as positive control. Quanti-
TPA treatment did not increase CAT activity from the AP- tative estimates of CAT enzyme (% conversion) and fold activation (rela-
tive to non-TPA-treated cultures) are shown below each lane.1 mutants pJZ24 and pJZ34 (Fig. 3). The data indicate
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FIG. 4. Effect of cell type on CAT expression from the ICP10 promoter. F9, SK-N-SH, and Vero cells were transfected with 1.0 mg of pJW24 (wild-
type ICP10 promoter) DNA in the presence (lanes 2, 5, and 8) or absence (lanes 1, 4, and 7) of 1.0 mg of c-Jun-encoding DNA (pSV-junA) and were
assayed for CAT activity 40 hr later. Cells transfected with 1.0 mg of pJZ24 (double AP-1 mutant) DNA (lanes 3, 6, and 9) served as control. Quantitative
estimates of CAT enzyme (% conversion) and fold activation (relative to pJW24 alone) are shown below each lane.
Jun caused a significant increase in CAT expression (Fig. stream AP-1 element, but the contribution of the down-
stream AP-1 element is not significantly different. Activa-4). In F9 and SK-N-SH cells, which lack or have minimal
levels of AP-1, CAT expression was respectively 11.3- tion was similarly reduced in cells transfected with pJZ2
or pJZ3 (Fig. 5), suggesting that ACT deletion (pJZ2) orand 17.7-fold higher in the presence of c-Jun than in its
absence. In Vero cells, in which the endogeneous AP-1 mutation of CT to AG (pJZ3) are equally capable of in-
terfering with AP-1-binding ability.basal levels are somewhat higher, CAT expression in
the presence of c-Jun was 40.5-fold higher than in its
AP-1 elements are involved in Vmw110-mediatedabsence (Fig. 4). As we have previously reported (Wymer
trans-activation of the ICP10 promoteret al., 1992), similar expression levels were seen for the
wild-type ICP10 promoter and the c-Jun-responsive plas-
Previous studies have shown that Vmw110 can acti-mid pTREcat (Angel et al., 1989) (12.3- and 13.7-fold acti-
vate the ICP10 (Wymer et al., 1989, 1992) or ICP6 (Desaivation, respectively in F9 cells).
et al., 1993) promoter. The mechanism of Vmw110-medi-In a second series of experiments, we examined the
effect of c-Jun on CAT expression from pICP10-cat and
its AP-1 mutants. Vero cells were cotransfected with c-
jun and pICP10-cat or its mutants in the upstream and/
or downstream AP-1 elements and CAT expression was
determined. In cells transfected with pICP10-cat and c-
jun CAT activity was 44-fold higher than in cells trans-
fected with pICP10-cat alone (Fig. 5). Activation levels
were significantly lower when c-jun was cotransfected
with ICP10 constructs mutated in the AP-1 elements. Mu-
tation in the upstream AP-1 element (pJZ2 and pJZ3)
caused a 60% reduction in CAT activity; mutation in the
downstream AP-1 element (pJZ4) caused a 40% reduction
in CAT activity compared to that seen for c-Jun-activated
pICP10-cat. Activation was abrogated only when both
AP-1 elements were mutated (pJZ24 and pJZ34) (Fig. 5).
FIG. 5. c-Jun activation of the ICP10 promoter. Vero cells were cotran-Activation was also abrogated when Vero cells were co-
sfected with 1.0 mg of target DNA consisting of the wild-type pICP10-transfected with pICP10cat and c-jun in the presence of
cat (pJW24), its upstream AP-1 mutants (pJZ2 and pJZ3), downstreamthe competing SV40 plasmid (data not shown). We inter-
AP-1 mutant (pJZ4), or double mutants (pJZ24 and pJZ34) and 1.0 mg
pret these data to indicate that the two AP-1 elements of c-Jun-encoding DNA (pSV-junA). Results are expressed as fold acti-
function independently, such that either one can respond vation over basal expression defined as CAT conversion in cells cotran-
sfected with pBR322 instead of activator DNA.to c-Jun. Major responsiveness is imparted by the up-
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activation was only twofold lower than that seen for
pICP10-cat (10.7 and 23.8% conversion for pJZ4 and
pICP10-cat, respectively). Vmw110-mediated activation
was virutually abrogated by mutation of both the up-
stream and the downstream AP-1 elements (0.9, 0.8, and
23.8% conversion for pJZ24, pJZ34, and pICP10-cat, re-
spectively). We interpret these findings to indicate that:
(i) both AP-1-binding sites in the ICP10 promoter are
involved in Vmw110-mediated transactivation and (ii) the
upstream AP-1-binding site is functionally more promi-
nent than the downstream AP-1-binding site.
Although the conversion levels were higher in 10%
serum, the results were similar to those obtained in 0.5%
serum (Fig. 6A). Thus, Vmw110-mediated activation of
the ICP10 promoter was reduced eightfold by mutation
of the upstream AP-1-response element (8.6, 9.3, and
67.1% conversion for pJZ3, pJZ2, and pICP10-cat, respec-
tively). Mutation of the downstream AP-1-response ele-
ment had a much lower effect on Vmw110-mediated acti-
vation (42 and 67.1% conversion for pJZ4 and pICP10-
cat, respectively) and activation was almost abrogated
by mutation of both AP-1 elements (3, 3.1, and 67.1 con-
version for pJZ24, pJZ34, and pICP10-cat, respectively).
The higher activation levels in 10% serum compared to
0.5% serum presumably reflect the contribution of theFIG. 6. Effect of AP-1 mutation on Vmw110-induced activation of the
ICP10 promoter. Vero cells were cotransfected with 1.0 mg of wild-type higher levels of endogenous AP-1 toward basal expres-
pICP10-cat (pJW24) or AP-1 mutant (pJZ2, pJZ3, pJZ4, pJZ24, and pJZ34) sion of the ICP10 promoter as evidenced by expression
target DNA and 0.3 mg of Vmw110-encoding DNA (pIGA15). They were from pICP10-cat alone (2.3 and 0.5% conversion at 10
exposed to 10% serum (A) or 0.5% serum (B) and assayed for CAT
and 0.5% serum respectively) (Figs. 6A and 6B).activity 40 hr later. Results, shown under each lane, are expressed as
We considered the possibility that the low activationpercentage of conversion and fold activation (over basal expression
defined as CAT conversion in cells cotransfected with pBR322 instead levels seen with the AP-1 mutants are not a specific
of activator DNA). response, but rather they reflect the low levels of basal
expression (below detection levels). To address this pos-
sibility, duplicate Vero cell cultures were cotransfected
ated activation is still unclear, but it appears to involve with pICP10cat (or its mutants) and Vmw110 or Vmw65
protein:protein interaction (Everett et al., 1993; Barlow et and were exposed to 0.5% serum. CAT activity was mea-
al., 1994; Ciufo et al., 1994; Meredith et al., 1995). Using sured 40 hr later. The oct/TAATGARAT mutant (pJW36;
deletion mutagenesis, Desai et al. (1993) concluded that Wymer et al., 1989) was used as control. As shown in
the TATA region of the ICP6 promoter is capable of re- Fig. 7, Vmw65 activated all constructs, except pJW36.
sponding to Vmw110 independent of other upstream ele- pJW36 was activated by Vmw110, but Vmw110 failed to
ments. However, since large deletions could cause unex- activate the AP-1 mutants. AP-1 cis-response elements
pected conformational changes, we constructed a panel are specifically involved in Vmw110-mediated activation,
of site-directed mutants in various upstream regulatory since CAT expression from mutants outside of the AP-1
elements and used them to examine Vmw110-mediated consensus sequence (shown here for pJZ53 and pJZ54)
activation. was similar to that seen for the wild-type construct. We
Vero cells (Fig. 6) were cotransfected with pICP10-cat conclude that the low activation levels seen for the AP-
or its mutants and Vmw110 and exposed to 0.5 or 10% 1 mutants are specific responses, independent of the
serum. CAT activity was determined 40 hr later. Unex- low levels of basal expression by these mutants, and
pectedly, Vmw110-mediated activation of the AP-1 mu- they are not due to a conformational defect resulting from
tants was significantly lower than that of pICP10-cat un- mutant construction.
der both experimental conditions. In 0.5% serum, muta-
tion of the upstream AP-1-response elements caused a Vmw110 can also activate the ICP10 promoter at the
significant reduction in Vmw110-mediated activation (2.2, TATA box
2.0, and 23.8% conversion for pJZ2, pJZ3, and pICP10-
cat, respectively) (Fig. 6B). Mutation of the downstream Because Desai et al. (1993) had shown that the TATA
region of the ICP6 promoter responds to Vmw110 inde-AP-1 element had a less pronounced effect, such that
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suggesting that it represents an AP-1-specific protein
complex (Fig. 8, lanes 2,4, and 6). Consistent with the
finding that cells infected with HSV-1 can induce AP-1
expression (Jang et al., 1991), the M2 band was signifi-
cantly (threefold) increased in assays of A/P-wt with ex-
tracts from HSV-1-infected, compared to mock-infected,
cells as determined by densitometric scanning (Fig. 8,
lanes 1 and 3).
In addition to complexes M1–M3, one band of lower
mobility (V1) was also observed in complexes formed by
the A/P-wt DNA probe with extracts from HSV-1-infected
cells (Fig. 8, lane 3). The V1 complex was not seen when
the HSV-1-infected cell extracts were reacted with the
A/P-mu DNA probe (Fig. 8, lane 4), suggesting that V1FIG. 7. Comparative effects of AP-1 mutation on Vmw110- and
Vmw65-induced activation of the ICP10 promoter. Vero cells were co- formation involves AP-1 cis-response elements. The V1
transfected with 1.0 mg of target DNA and 0.3 mg of activator DNA complex was also not observed when the A/P-wt DNA
under 0.5% serum conditions. Target DNA consisted of the wild-type fragment was incubated with extracts of cells infectedpICP10-cat (pJW24), its upstream AP-1 (pJZ2, pJZ3), its downstream
with the Vmw110 deletion mutant dl1403 (Fig. 8, lane 5).AP-1 (pJZ4), double AP-1 (pJZ24, pJZ34), and non-AP-1 (pJZ53, pJZ54)
We interpret these findings to indicate that both AP-1 andmutants. pJW34, mutated in oct/TAATGARAT (Wymer et al., l989, 1990),
and pJZD5, deleted in all the upstream regulatory elements, were also Vmw110 are involved in the formation of the V1 complex.
used as target DNAs. Activator DNAs were pIGA15 (encodes Vmw110) Similar results were obtained with nuclear extracts pre-
and pGH62 (encodes Vmw65). Results are shown as fold activation
pared in 1% serum (data not shown).over basal expression defined as CAT conversion in cells cotransfected
Two series of experiments were done to further exam-with pBR322 instead of activator DNA.
ine the validity of this interpretation. First we did competi-
tion experiments with synthetic oligonucleotides that en-
pendent of other promoter elements, an ICP10 mutant
(pJZD5) deleted in all sequences upstream of the TATA
box was studied in parallel with the AP-1 mutants in Vero
cells cotransfected with Vmw65 or Vmw110. As shown
in Fig. 7, CAT expression from pJZD5 was not increased
by cotransfection with Vmw65, but it was activated by
cotransfection with Vmw110. Of interest, activation levels
were only 2-fold lower than those seen for the wild-type
promoter and significantly (10-fold) higher than those
seen for the double AP-1 mutants (Fig. 7). We interpret
these findings to indicate that Vmw110 trans-activates
the ICP10 promoter through interaction with AP-1 factors
at AP-1 cis-response elements. However, in the absence
of these elements, Vmw110 can also function to activate
ICP10 at the TATA box, presumably through complex
formation between protein factors at the TATA box.
Activation by Vmw110 correlates with protein
complex formation at AP-1-binding sites
In order to verify if ICP0 can complex with AP-1 tran-
scription factors in the context of the ICP10 promoter,
wild-type and double AP-1 mutant ICP10 promoter frag-
ments were assayed in gel retardation assays with nu-
clear extracts from Vero cells mock infected or infected
with HSV-1 or the Vmw110-deletion mutant dl1403 (m.o.i.
FIG. 8. Gel retardation analysis with the wild-type ICP10 and mutant 5; 5 hr postinfection) in medium with 10% serum. Three
AP-1 promoters. The 61-bp AflIII/PvuI DNA fragments from the wild-complexes designated M1 through M3 in order of in-
type construct pJW24 (A/P-wt, lanes 1, 3, and 5) or the double-AP-1creasing electrophoretic mobility were formed by the
mutant pJZ34 (A/P-mu, lanes 2, 4, and 6) were incubated with nuclear
wild-type DNA fragment (A/P-wt) with extracts from extracts from Vero cells mock infected (lanes 1 and 2) or infected (m.o.i.
mock-infected cells (Fig. 8, lane 1). The M2 complex was  5) for 5 hr with HSV-1 (lanes 3 and 4) or the Vmw110 mutant dl1403
(lanes 5 and 6).not seen with the AP-1 mutant DNA fragment (A/P-mu),
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the synthetic oligonucelotide containing only AP-1 motifs
(but not an AP-1 mutant oligonucleotide) and it was not
supershifted by c-Fos antibody (Fig. 9, lanes 4 and 8),
we interpret the data to indicate that M2 is a Jun/Jun
homodimer complex. However, in the absence of su-
pershift experiments with c-Jun antibody, we do not ex-
clude the possibility that a factor other than c-Jun can
also bind at this site.
DISCUSSION
During lytic infection, HSV gene expression is regu-
lated in a cascade fashion commencing with the synthe-
sis of the IE gene products followed by the synthesis of
the E and L classes of gene products (Honess and Roiz-
man, 1974). The RR1 genes of HSV-2 and HSV-1 (ICP10
and ICP6, respectively) have been classified as belong-
ing to the E class of genes. However, they are unique
among the E genes in that: (i) they contain the octamer/
TAATGAARAT sequence and respond to activation by the
Vmw65/oct-1 complex (Wymer et al., 1989, 1992; Desai et
al., 1993), (ii) their expression is regulated by Vmw110,FIG. 9. Competition and supershift assays. The 61-bp AflIII/PvuI DNA
fragment from the wild-type construct pJW24 was incubated with nu- but not ICP4 (Wymer et al., 1989, 1992; Desai et al., 1993),
clear extracts from Vero cells infected (5 hr, m.o.i.  5) with HSV-1 and (iii) their 5* regulatory region contains AP-1 cis-re-
(lanes 1–4) or the Vmw110 mutant dl1403 (lanes 5–8) in the absence sponse elements which specifically bind in vitro-trans-
(lanes 1 and 5) or presence of 50-fold excess cold synthetic oligonucle-
lated c-Jun (Wymer et al., 1989, 1992).otide AP-1 competitor (oligo-AP, lanes 2 and 5), oligonucleotide mutant
Inasmuch as RR1 has the only HSV gene promoterAP-1 competitor (oligo-DAP, lanes 3 and 6), or c-Fos antibody (c-Fos
Ab, lanes 4 and 8). which has conserved AP-1 cis-response elements, the
question arises whether these elements play a signifi-
cant role in RR1 gene expression. The AP-1 family of
compass the wild-type AP-1-binding site (oligo-AP) or an transcription factors belongs to the bZIP protein family
AP-1 mutant oligonucleotide (oligo-DAP). In these experi- and contains Jun- and Fos-related proteins (Vinson et al.,
ments, the wild-type DNA fragment (A/P-wt) was mixed 1989). It consists of Jun/Jun homodimers and heterodim-
with nuclear extracts from HSV-1 or dl1403-infected cells ers between the Jun and Fos subgroups (reviewed in
in the presence or absence of 50-fold excess of oligonu- Angel and Karin, 1991). DNA recognition sequences for
cleotide competitors. Oligo-AP effectively competed for- AP-1 are frequent components of complex regulatory ele-
mation of the M2 and V1 complexes with extracts of HSV- ments in IE cellular genes (Lee et al., 1987). AP-1 tran-
1-infected cells (Fig. 9, lane 2). Their formation was not scription factors can also interact with members of other
competed by oligo-DAP (Fig. 9, lane 3). The M2 complex transcription factor families containing unrelated DNA
formed by A/P-wt with dl1403-infected cells was also binding motifs (Henderson and Stein, 1994), with Jun and
competed by oligo-AP (Fig. 9, lane 6), but not by oligo- possibly other members of the family serving as a link
DAP (Fig. 9, lane 7). The V1 complex was not seen with between different signal pathways. AP-1 cis-response
extracts of dl1403-infected cells. These observations elements are essential for baseline activity of some pro-
support the conclusion that AP-1 response elements are moters, such as the endothelin-1 or human papillomavi-
involved in the formation of both the M2 and the V1 rus, in a cell-restricted fashion (Butz and Hoppe-Seyler,
complexes. 1993; Kawana et al., 1995; Kyo et al., 1995).
In the second series of experiments, gel retardation Our data suggest that at least one of the two AP-1 cis-
assays were done with the A/P-wt DNA fragment and response elements is required for basal expression from
extracts of HSV-1- or dl1403-infected cells in the pres- the ICP10 promoter. Indeed, CAT expression from the
ence of c-Fos antibody. Addition of the c-Fos antibody to wild-type ICP10 promoter was significantly higher in 10
the HSV-1-infected cell extracts retarded V1 migration than in 0.5% serum, and basal expression from the ICP10
(Fig. 9, lane 4), but had no effect on the migration of promoter was abrogated by mutation of either AP-1 ele-
complexes formed with dl1403-infected cell extracts (Fig. ment. In F9 cells, that lack AP-1 transcription factors
9, lane 8). We interpret these data to indicate that the V1 (Angel et al., 1989), CAT expression from the wild-type
complex contains a c-Fos AP-1 complex and Vmw110. ICP10 promoter was much lower than in Vero cells that
retain some endogenous AP-1, even after culture in 0.5%Because the M2 complex was effectively competed with
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serum. The upstream AP-1 element appeared to play a wild-type but not the mutant AP-1 oligonucleotide. Su-
pershift experiments with c-Fos antibody indicated thatmore prominent role than the downstream element in
promoter induction by c-Jun or Vmw110, since its muta- c-Fos is present in the V1 complex. Supershift assays
with c-Jun antibody were not done, but it is likely that c-tion had a more dramatic effect on the promoter. How-
ever, response was only abrogated by mutation of both Jun is also present in the V1 complex because c-Fos
cannot form homodimers, and it must complex with c-AP-1 elements. Similar reduction in CAT expression was
observed following ACT deletion (in TGACTCA) or CT Jun to bind to AP-1-response elements. The interaction
appears to be specific for the c-Jun/c-Fos heterodimer,mutation (to AG), indicating that these sequences are
required for AP-1 binding. The AP-1 effects are specific because the M2 complex was not supershifted by the c-
Fos antibody, suggesting that it consists of c-Jun homo-as indicated by the observation that mutation of adjacent
sequences (such as GG:AG and GG:GA, Fig. 1) did not or heterodimers. However, we do not exclude the contri-
bution of additional factors such as Ets-1, or other factors,affect basal expression or c-Jun-mediated activation.
As previously reported (Wymer et al., 1989), we find which may modulate enhancer functions. Presumably,
Vmw110 is recruited to the AP-1 cis-response elementsthat Vmw110 activates expression from the ICP10 pro-
moter. The mechanism of Vmw110-mediated activation of through its interaction with the c-Jun/c-Fos heterodimer.
In this context it may be significant that in vitro-translatedgene expression is still unclear, but it appears to involve
protein:protein interactions. Mutational analysis of the c-Jun protein was previously shown to specifically bind
to AP-1 elements in gel retardation assays (Wymer etparts of Vmw110 which are required for its function has
revealed the importance of a novel form of Zn2/-binding al., 1992). Studies designed to identify the c-Jun family
members involved in complex formation with Vmw110domain, called the RING finger (Everett et al., 1993; Bar-
low et al., 1994). Another important domain, toward the are ongoing in our laboratory. This is particularly signifi-
cant since the closely related Jun family members canC-terminal end of the protein, has been shown to bind
an as yet uncharacterized 135-kDa cellular protein (Mer- exhibit distinct roles in regulating transcription of various
genes (Angel and Karin, 1991). Although our data suggestedith et al., 1994) and to contain a possible multimeriza-
tion motif (Ciufo et al., 1994). Our findings for the ICP10 that CT residues within the AP-1-binding elements play
an important role in basal expression from the ICP10promoter are consistent with these interpretations, and
indicate that AP-1 is specifically involved in Vmw110- promoter, as well as its activation, methylation interfer-
ence assays are required in order to definitively identifymediated activation. Thus: (i) activation was not reduced
by mutation of other nucleotides in the ICP10 5*-regula- the contact bases involved in V1 complex formation.
We note that deletion of all the recognizable regulatorytory region (outside the AP-1 consensus elements), (ii)
mutation of the upstream AP-1 element had a more pro- sequences upstream of the TATA region had little effect
on the induction of CAT activity by Vmw110, suggestingnounced effect on activation than that of the downstream
element, (iii) activation was abrogated by mutation of that the ICP10 TATA region is susceptible to activation
by Vmw110, as previously reported for ICP6 (Desai et al.,both AP-1 cis-response elements, and (iv) the AP-1 mu-
tants responded as well as the wild-type ICP10 promoter 1993). Possibly interaction of transcription factors at the
TATA box is enabled by conformational changes re-to activation by Vmw65.
Additional evidence in support of the interpretation that sulting from the deletion of all upstream regulatory ele-
ments. Alternatively, expression from the wild-type RR1AP-1 is involved in Vmw110-induced activation of the
ICP10 promoter is the observation that Vmw110 partici- promoter reflects the balance between positive (AP-1)
and negative (as yet unknown) regulatory elements, withpates with c-Fos in protein complex formation at the AP-
1 cis-response elements. The AflII/PvuI DNA fragment mutation in the AP-1 cis-response elements, tipping the
balance in favor of negative regulation. The ICP6 pro-encompassing the two AP-binding motifs from the wild-
type ICP10 promoter formed a complex (M2) with nuclear moter lacks the downstream AP-1 cis-response element
(at position 062), thereby increasing the absolute dis-extracts from mock-infected cells that was not seen with
the same DNA fragment from the double-AP-1 mutant, tance between the AP-1 site and the TATA box relative
to that seen in ICP10. However, Vmw110-mediated acti-suggesting that it represents an AP-1-specific protein
complex. Another complex (V1) was seen in gel retarda- vation of the ICP10 promoter was decreased by mutation
of either AP-1 site, suggesting that they function indepen-tion assays using the wild-type ICP10 DNA fragment and
nuclear extracts of HSV-1-infected cells, but not extracts dently.
What is the significance of AP-1 regulation of RR1 infrom cells infected with a Vmw110-deletion mutant, sug-
gesting that Vmw110 is involved in V1 complex formation. HSV pathogenesis? Since our experiments were done in
a transient expression system, it remains to be deter-We conclude that AP-1 factors are also involved in V1
complex formation since V1 was not seen when the DNA mined whether similar ICP10 regulatory conditions also
apply to virus-infected cells. Studies ongoing in our labo-fragment from the double AP-1 mutant was used in gel
shift mobility assays with nuclear extracts from HSV-1- ratory are designed to address this question. However,
it seems reasonable to conclude that the distinctive regu-infected cells, and its formation was competed by the
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lation of the RR1 gene is unlikely to be associated with of the ICP10 promoter are mutated. Comparison between
these viruses and the wild-type HSV-2 in infection andits role in RR activity since the latter depends on the
expression of RR2, which is regulated with classical E latency may provide clues to the unique role of ICP10 in
virus pathogenesis.kinetics. Inasmuch as RR1 is a multifunctional protein
the PK activity of which is independent of its RR activity
(Chung et al., 1989; Conner et al., 1992b; Lankinen et al., ACKNOWLEDGMENTS
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